Crescendo Biologics to attend 36th Annual J.P. Morgan Healthcare Conference 2018, San Francisco Cambridge, UK, 2 January 2018 – Crescendo Biologics Limited (Crescendo), the drug developer of novel, targeted T-cell enga - J.P. Morgan - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2018-01-02 07:03:43		Crescendo Biologics to attend 36th Annual J.P. Morgan Healthcare Conference 2018, San Francisco Cambridge, UK, 2 January 2018 – Crescendo Biologics Limited (Crescendo), the drug developer of novel, targeted T-cell enga Add to Reading List Source URL: www.crescendobiologics.com Download Document from Source Website File Size: 273,14 KB Share Document on Facebook